Evidence map›Paper›PMID 41261784›Full record

ReviewThoracic cancer2025

Revisiting Cancer Cachexia Staging: Introducing an "At Risk" Category Based on AWGC Components.

Tatsuma Sakaguchi, Keisuke Maeda, Makoto Yamasaki, Naoharu Mori

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tatsuma SakaguchiDepartment of Upper Gastrointestinal Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
Keisuke MaedaDepartment of Palliative and Supportive Medicine, Graduate School of Medicine, Aichi Medical University, Nagakute, Aichi, Japan.ORCID https://orcid.org/0000-0001-7132-7818
Makoto YamasakiDepartment of Upper Gastrointestinal Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
Naoharu MoriDepartment of Palliative and Supportive Medicine, Graduate School of Medicine, Aichi Medical University, Nagakute, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer cachexia is a multifactorial syndrome characterized by progressive weight loss, muscle wasting, and systemic inflammation. Early identification of individuals at risk for cachexia is essential for timely intervention, yet a universally accepted definition of the "at risk" stage remains lacking. Building on the Asian Working Group for Cachexia (AWGC) framework, we propose that the presence of any one of the five components-low BMI (< 21 kg/m

Indexed as

CachexiaNeoplasmsAgedAged, 80 and overBody Mass IndexFemaleHand StrengthHumansMaleMiddle AgedNeoplasm StagingPrognosisRisk FactorsAsian Working Group for Cachexiaat risk of cachexiacancer cachexiaprecachexia

Identifiers

PMID41261784
PMCPMC12630547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.